Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2024-07-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 4.746 -3,000
2024-07-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 3,000
2024-07-25 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 70 -15,571
2024-07-22 FOXO / FOXO Technologies Inc. 4 WARD MARTIN CHRISTOPHER By KR8 ai Inc. S - Sale I 0.25 -1,300,000
2024-07-22 FOXO / FOXO Technologies Inc. 4 Kr8 ai Inc. S - Sale D 0.25 -1,300,000
2024-07-22 FOXO / FOXO Technologies Inc. 4 WHITE MARK BRIAN By KR8 ai Inc. S - Sale I 0.25 -1,300,000
2024-07-16 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 64.19 -1,306
2024-07-15 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 64.25 -1,111
2024-07-15 INCY / Incyte Corporation 4 Iyengar Vijay K F - Taxes D 64.25 -549
2024-07-15 INCY / Incyte Corporation 4 Stein Steven H F - Taxes D 64.25 -1,555
2024-07-15 INCY / Incyte Corporation 4 Stamoulis Christiana F - Taxes D 64.25 -948
2024-07-15 INCY / Incyte Corporation 4 Hoppenot Herve F - Taxes D 64.25 -4,961
2024-07-15 INCY / Incyte Corporation 4 SWAIN PAULA J F - Taxes D 64.25 -549
2024-07-15 INCY / Incyte Corporation 4 CAGNONI PABLO J F - Taxes D 64.25 -749
2024-07-15 INCY / Incyte Corporation 4 Tray Thomas F - Taxes D 64.25 -466
2024-07-15 INCY / Incyte Corporation 4 CAGNONI PABLO J A - Award D 19,851
2024-07-15 INCY / Incyte Corporation 4 Trotta Matteo A - Award D 2,646
2024-07-15 INCY / Incyte Corporation 4 Flannelly Barry P A - Award D 9,925
2024-07-15 INCY / Incyte Corporation 4 Denton Sheila A. A - Award D 5,955
2024-07-15 INCY / Incyte Corporation 4 Tray Thomas A - Award D 5,073
2024-07-15 INCY / Incyte Corporation 4 SWAIN PAULA J A - Award D 7,278
2024-07-15 INCY / Incyte Corporation 4 Hoppenot Herve A - Award D 41,025
2024-07-15 INCY / Incyte Corporation 4 Stein Steven H A - Award D 13,895
2024-07-15 INCY / Incyte Corporation 4 Stamoulis Christiana A - Award D 12,572
2024-07-15 INCY / Incyte Corporation 4 Iyengar Vijay K A - Award D 7,278
2024-07-12 OABI / OmniAb, Inc. 4 Cochran Jennifer R. M - Exercise D 1,896
2024-07-09 MXCT / MaxCyte, Inc. 4 Ross Thomas M. S - Sale D 4.034 -13,531
2024-07-09 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 60 -8,148
2024-07-09 MXCT / MaxCyte, Inc. 4 Ross Thomas M. M - Exercise D 1.641 13,531
2024-07-08 MXCT / MaxCyte, Inc. 4 Ross Thomas M. S - Sale D 4.029 -19,802
2024-07-08 MXCT / MaxCyte, Inc. 4 Ross Thomas M. M - Exercise D 1.641 19,802
2024-07-02 INCY / Incyte Corporation 4 Hoppenot Herve F - Taxes D 59.02 -41,723
2024-07-02 INCY / Incyte Corporation 4 Tray Thomas F - Taxes D 59.02 -844
2024-07-02 INCY / Incyte Corporation 4 Stamoulis Christiana F - Taxes D 59.02 -6,870
2024-07-02 INCY / Incyte Corporation 4 Iyengar Vijay K F - Taxes D 59.02 -5,706
2024-07-02 INCY / Incyte Corporation 4 SWAIN PAULA J F - Taxes D 59.02 -5,560
2024-07-02 INCY / Incyte Corporation 4 Stein Steven H F - Taxes D 59.02 -8,316
2024-07-02 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 59.02 -7,695
2024-07-01 BIAF / bioAffinity Technologies, Inc. 4 Joyce Roby A - Award D 33,784
2024-07-01 BIAF / bioAffinity Technologies, Inc. 4 Anderson Robert A. A - Award D 33,784
2024-07-01 BIAF / bioAffinity Technologies, Inc. 4 Rubin Gary D A - Award D 33,784
2024-07-01 BIAF / bioAffinity Technologies, Inc. 4 KNIGHT PETER S A - Award D 33,784
2024-07-01 BIAF / bioAffinity Technologies, Inc. 4 Platt Jamie A - Award D 33,784
2024-07-01 BIAF / bioAffinity Technologies, Inc. 4 DIAMOND STUART A - Award D 33,784
2024-07-01 BIAF / bioAffinity Technologies, Inc. 4 Zannes Maria A - Award D 33,784
2024-07-01 BIAF / bioAffinity Technologies, Inc. 4 GIRGENTI STEVEN A - Award D 33,784
2024-06-30 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 72
2024-06-30 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 62
2024-06-30 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 78
2024-06-29 OABI / OmniAb, Inc. 4 Avista Capital Managing Member V, LLC See Notes M - Exercise I 3.35 66,668
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)